Plaintiffs are pushing back against an attempt by generic drug manufacturers and repackagers to dismiss ranitidine class action lawsuits filed over the risk of cancer from high levels of the chemical byproduct found in all versions of the heartburn drug, which was more commonly known by the brand name Zantac. Over the past year, ranitidine…